After 13 years at the agency, CDRH Digital Health Center of Excellence director Bakul Patel announces he will be leaving the agency early this month t...
FDA Review posts the Federal Register notices for the week ending 4/29/2022.
FDA Review posts product approval summaries for the week ending 4/29/2022.
FDA posts a draft guidance entitled Crohns Disease: Developing Drugs for Treatment that discusses clinical trial considerations.
Federal Register notice: FDA issues a priority review voucher to Gilead Sciences under the agencys material threat medical countermeasure program.
FDA lifts a clinical hold on a Finch Therapeutics Group IND for CP101, an orally administered microbiome therapeutic which is in late-stage clinical d...
FDA announces the tentative Vaccines and Related Biological Products Advisory Committee schedule that has five separate dates the panel will meet to r...